Samedan Ltd Pharmaceutical Publishers


Advanced search

Publications European Pharmaceutical Contractor European Biopharmaceutical Review International Clinical Trials Pharmaceutical Manufacturing and Packing Sourcer Innovations in Pharmaceutical Technology Subscribe Online Conferences White Papers Samedan app Pharmaceutical Directory Industry Events Calendar News and Press Releases Employment Opportunities Advertising with us Contact Us

Innovations in Pharmaceutical Technology

IPT was launched in 1997 to provide the pharmaceutical industry with quality information on the latest cutting-edge technologies.

International Clinical Trials

ICT is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.

Pharmaceutical Manufacturing and Packing Sourcer

PMPS is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.

European Biopharmaceutical Review

EBR is well-recognised for providing beneficial information to players in the bio-industry including entrepreneurial biopharmaceutical and life science companies

EPC

Preserving Trial Integrity During a Pandemic

Karen Ooms at Quanticate

In the face of COVID-19, clinical trials have a greater need for flexibility, but they still shouldn’t affect patients’ safety or compromise study validity

Collaboration in Pharma

Synergistic Relations

Fran DeGrazio at West Pharmaceutical Services, Inc

In this fast-paced and complex technical and regulatory environment, pharmaceutical and biotechnology companies are looking for new ways to become more efficient while building processes that deliver new drugs to market in a timely, cost-effective manner.

Features

The Numerous Challenges of a Rapidly Developing Sector

Carl Niedbala at Founder Shield

Now, more than ever, the biotech industry faces a significant number of risks, including a lengthy pipeline, the complicated process of gaining FDA approval, and higher healthcare costs.

Website design and development by Rubler Studio

Member login

E-mail address:

Password:
Remember me

News and Press Releases

Byondis’ Investigational Antibody-Drug Conjugate SYD985 Selected for I-SPY 2 TRIAL™ in Early-Stage Breast Cancer

Byondis B.V. (formerly Synthon Biopharmaceuticals) today announced that Quantum Leap Healthcare Collaborative™ (Quantum Leap) selected the company’s investigational antibody-drug conjugate (ADC) SYD985 ([vic-]trastuzumab duocarmazine) for a new investigational treatment arm in its ongoing I-SPY 2 TRIAL™ for neoadjuvant treatment of locally advanced breast cancer.
More info >>

All releases >>

	White Papers
All white papers >>

Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>

All events >>